BsR: Reduction of Intraoperative EEG Burst Suppression

Sponsor
Technische Universität München (Other)
Overall Status
Completed
CT.gov ID
NCT03775356
Collaborator
(none)
106
1
2
23.4
4.5

Study Details

Study Description

Brief Summary

Burst suppression (BS) is a not physiological pattern in the electroencephalogram (EEG). BS during general anesthesia is mainly seen as a sign for too deep hypnosis and may increase the risk of postoperative delirium (POD), a disturbance of consciousness arising within 24 hours after surgery. This monocentric, simple masked randomized study aims primarily to investigate, whether particular anesthesiological interventions reduce the occurrence of intraoperative burst suppression. The investigator initiated trial includes 66 patients (male and female) aged ≥ 60 years in two groups (intervention and control group). Secondary aims will be the correlation of burst suppression and mean arterial pressure, concentration of anesthetics and postoperative delirium.

Condition or Disease Intervention/Treatment Phase
  • Other: Treatment of hypotension and/or reduction of anesthetics
N/A

Detailed Description

Intraoperative burst suppression represents a non physiological EEG pattern. According to the literature and scientific knowledge, intraoperative burst suppression patterns might be caused either by hypotension resulting in a reduced cerebral circulation or by an oversedation of anesthetics correlating with a very deep level of hypnosis.

Some publications exist that discuss the occurrence of intraoperative burst suppression especially in elderly people (aged ≥ 60 years) as a predictor of postoperative delirium and postoperative cognitive dysfunction.

None of the studies however was able to prove a causal relationship between burst suppression and postoperative delirium. Contrary it might simply be an epiphenomenon.

Conducting this interventional trail primarily aims to prove whether specific anesthesiological interventions, such as the treatment of intraoperative hypotension in first line and/or the reduction of the concentration of anesthetics in second line, reduce intraoperative burst suppression. Hence it might be possible to investigate a possible casualty between burst suppression and postoperative delirium in a second trial.

Study Design

Study Type:
Interventional
Actual Enrollment :
106 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Investigator)
Masking Description:
Single masked. The entropy and EEG module will be masked for the responsible anesthetist as well as the study team during the entire investigation.
Primary Purpose:
Prevention
Official Title:
Reduction of Intraoperative EEG Burst Suppression - Test of Efficacy
Actual Study Start Date :
Jan 8, 2019
Actual Primary Completion Date :
Dec 19, 2020
Actual Study Completion Date :
Dec 19, 2020

Arms and Interventions

Arm Intervention/Treatment
No Intervention: 1 - Blinded

EEG and Entropy will be blinded. The anesthesiological management will be performed by the anesthetist according to clinical standard operations.

Active Comparator: 2 - Unblinded

EEG and Entropy will be unblinded. The intervention starts with the start of a positive burst suppression rate. In the case of a concurrent hypotension the anesthetist treats the hypotension according to clinical standard operations in the first step. Hypotension means blood pressure values blow the baseline value which is defined by the lowest, preoperatively measured value. If after this treatment and a reevaluation of the BSR, BSR remains positive, the anesthetist is going to reduce the concentration of anesthetics in a second step. In case of positive BSR and a blood pressure value ≥ the baseline value, the concentration of anesthetics will be reduced as a first measure. The aim is to figure out whether one or both of these interventions can reduce to total, cumulative BSR.

Other: Treatment of hypotension and/or reduction of anesthetics
The treatment of hypotension can be done by the responsible anesthetist according to the clinical standard operations including any accepted drug typically used in this hospital. The reduction of anesthetics can be done either by reducing the volatile end tidal anesthetics concentration (ETAC) or the infusion rate of propofol.

Outcome Measures

Primary Outcome Measures

  1. Chance of the total, cumulative burst suppression rate. [During general anesthesia and within the intervention]

    The total, cumulative burst suppression rate (BSR) corresponds to area under the curve and is defined by the BSR (%) and the absolute duration of BSR (t).

Secondary Outcome Measures

  1. Burst suppression rate during induction. [During induction within the intervention]

    Rate of change of the burst suppression rate during induction.

  2. Burst suppression rate during maintenance. [During maintenance within the intervention]

    Rate of change of the burst suppression ratio during maintenance.

  3. Mean arterial blood pressure. [During burst suppression within general anesthesia]

    Evaluation of the mean arterial blood pressure with positive burst suppression rate.

  4. Endtidal anesthetic concentration (ETAC) and infusion rate of propofol. [During burst suppression within the intervention]

    Evaluation of the mean ETAC and infusion rate of propofol.

  5. Specific characteristics of the EEG frequency spectrum during burst suppression [During burst suppression within general anesthesia]

    Evaluation of specific EEG frequencies differentiating BSR caused by hypotension or oversedation of anesthetics.

  6. Postoperative delirium. [Within the first three postoperative days]

    Screening of the patients regarding a postoperative delirium by a brief confession assessment method (bCAM).

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 60 years

  • Surgical interventions in general anesthesia (volatile or total intravenous anesthesia)

  • expected surgery duration ≥ 1h

  • American Society of Anesthesiologists (ASA) 1-4

  • written informed consent prior to study participation

Exclusion Criteria:
  • Neurological or psychiatric disorders

  • hearing difficulty

  • deafness

  • neurosurgical (intra)cranial surgery

  • pregnancy

  • expected continuous mandatory ventilation after surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Klinikum rechts der Isar - Klinik fuer Anaesthesiologie und Intensivmedizin München Bayern Germany 81675

Sponsors and Collaborators

  • Technische Universität München

Investigators

  • Principal Investigator: Gerhard Schneider, Prof. Dr., Clinic director - Department of anesthesiology and intensive care

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Technische Universität München
ClinicalTrials.gov Identifier:
NCT03775356
Other Study ID Numbers:
  • BsR
First Posted:
Dec 13, 2018
Last Update Posted:
May 11, 2021
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Technische Universität München
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2021